| Michigan City In | |
|
2206 Roosevelt Rd Ste A Valparaiso IN 46383-2749 | |
| (219) 464-9507 | |
| (219) 477-4690 |
| Full Name | Michigan City In |
|---|---|
| Speciality | Internal Medicine - Gastroenterology |
| Location | 2206 Roosevelt Rd, Valparaiso, Indiana |
| Authorized Official Name and Position | Thomas R Hall (SECRETARY) |
| Authorized Official Contact | 2194649507 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Michigan City In 2206 Roosevelt Rd Ste A Valparaiso IN 46383-2749 Ph: (219) 464-9507 | Michigan City In 2206 Roosevelt Rd Ste A Valparaiso IN 46383-2749 Ph: (219) 464-9507 |
| NPI Number | 1144325614 |
|---|---|
| Provider Enumeration Date | 09/13/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144325614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.1 billion in 2019.
Gene therapy for a severe inherited blindness, which produced dramatic improvements last year in 12 children and young adults who received the treatment in a clinical trial, has cleared another hurdle. The same research team that conducted the human trial now reports that a study in animals has shown that a second injection of genes into the opposite, previously untreated eye is safe and effective, with no signs of interference from unwanted immune reactions following the earlier injection.
YM BioSciences Inc. today announced positive interim data from the first 60 patients enrolled in the Phase I/II trial for its JAK1/JAK2 inhibitor, CYT387, in myelofibrosis. The results were reported today in an oral presentation at the 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida.
According to a recent longitudinal study in children, inactivity does not lead to fatness! Moreover, the authors concluded that fatness is driving inactivity, and not the other way around. The authors noted that this "reverse causality" explains the observed association between inactivity and fatness. It also explains the repeated failures of the attempts to reduce childhood obesity by increasing physical activity. The study was published in the Archives of Disease in Childhood by Dr. Brad Metcalf and colleagues from Plymouth, UK.
› Verified 4 days ago
Healthlinc - Porter-starke Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 Wall St, Valparaiso, IN 46383 Phone: 219-299-8419 Fax: 219-462-7504 | |
Indiana Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 407 E Lincolnway, Valparaiso, IN 46383 Phone: 888-339-7339 | |
New Beginnings Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 Fordwick Ln, Valparaiso, IN 46383 Phone: 219-671-1881 | |
B Waldo Md Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3000 Pepper Creek Bridge Pkwy, Valparaiso, IN 46385 Phone: 773-520-1950 | |
Sudhakar Garlapati Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Wall St, Valparaiso, IN 46383 Phone: 219-462-2106 | |
James E. Taylor Medical Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2102 Evans Ave, Suite 111, Valparaiso, IN 46383 Phone: 219-464-9521 |